Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-21-016612
Filing Date
2021-10-27
Accepted
2021-10-27 07:19:24
Documents
3
Period of Report
2021-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp160551_6k.htm 6-K 9852
2 EXHIBIT 99.1 dp160551_ex9901.htm EX-99.1 7347
3 GRAPHIC image_001.jpg GRAPHIC 4375
  Complete submission text file 0000950103-21-016612.txt   24388
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 211350686
SIC: 2834 Pharmaceutical Preparations